COMBINATION VACCINES AGAINST CORONAVIRUS INFECTION, INFLUENZA INFECTION, AND/OR RSV INFECTION

MULTIEPITOPE UNIVERSAL INFLUENZA VACCINE

NUCLEIC ACID VACCINES

CsgA-DERIVED NANOSTRUCTURES AND USES THEREOF FOR ANTIGEN DELIVERY

MEMBRANE VESICLES COMPRISING MULTIPLE INFLUENZA ANTIGENS FOR VACCINES

MODIFIED INFLUENZA VIRUSES

METHOD FOR PREVENTION AND TREATMENT OF VIRAL DISEASE

Mutated Influenza Virus, Pharmaceutical Composition, and Use

METHOD OF DETERMINING NEUTRALIZING ANTIBODIES USING MODIFIED HEMAGGLUTINATION ASSAYS

FUSION PROTEIN AND VACCINE

PSEUDO-VIRAL PARTICLES AND USES OF SAME

MODIFIED LIVE ATTENUATED FLU VIRUS VACCINES AND USES THEREOF

BROADLY REACTIVE IMMUNOGENS OF INFLUENZA H3 VIRUS, COMPOSITIONS AND METHODS OF USE THEREOF

MRNA ENCODING INFLUENZA VIRUS-LIKE PARTICLE

IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION OF INFLUENZA A

INFLUENZA VIRUS VACCINES AND USES THEREOF

CORONAVIRUS IMMUNOGEN COMPOSITIONS AND THEIR USES

COMPOSITIONS FOR OPTIMIZED INFLUENZA PEPTIDE VACCINES

IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA

DEOPTIMIZED INFLUENZA VIRUSES AND METHODS OF TREATING CANCER

POLYPEPTIDE FRAGMENTS, IMMUNOGENIC COMPOSITION AGAINST INFLUENZA VIRUS, AND IMPLEMENTATIONS THEREOF

Dual-Action Recombinant Vesicular Stomatitis Virus (RVSV)-Based Vaccine (DAV) Against COVID-19 and Influenza Viruses

PATHOGEN-LIKE ANTIGEN-BASED VACCINE AND PREPARATION METHOD THEREFOR

IMMUNOSTIMULATORY PREPARATION AND COSMETIC, FOOD, FEED ADDITIVE, AND QUASI-PHARMACEUTICAL PRODUCT CONTAINING THE IMMUNOSTIMULATORY PREPARATION

AVIAN INFLUENZA VIRUS VACCINES

NUCLEIC ACID CONSTRUCT AND USE THEREOF

VACCINE

CONSTRUCTION OF NOVEL HUMAN INFLUENZA VIRUS VACCINE AND APPLICATION

VIRUS-LIKE PARTICLE STABLY EXPRESSED BY ANIMAL CELLS AS VACCINE ANTIGEN AGAINST COVID-19 AND INFLUENZA VIRUS

MRNA EXPRESSION AND DELIVERY SYSTEMS

FUSION PROTEIN AND USE THEREOF

EPITOPE FOCUSING BY VARIABLE EFFECTIVE ANTIGEN SURFACE CONCENTRATION

FUSION PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF

NOVEL IMMUNOGENS FOR INFLUENZA VIRUS VACCINES

INFLUENZA VIRUS HEMAGGLUTININ MUTANTS

INFLUENZA VIRUS HEMAGGLUTININ PROTEINS AND USES THEREOF

INFLUENZA VIRUS MUTANTS AND USES THEREFOR

VIRAL VECTORED VACCINES FOR SWINE INFLUENZA VIRUS AND METHODS OF USE

ADENOVIRAL VECTOR SYSTEM FOR GENE DELIVERY

Multicistronic Vaccine and Methods for Producing and Using the Same

INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT

IMMUNOGENIC COMPOSITIONS AND THEIR USES

PARENTERALLY ADMINISTRABLE INFLUENZA VACCINE AND USES THEREOF

AGENTS THAT ENGAGE ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL ASIALOGLYCOPROTEIN RECEPTOR (DC-ASGPR)

EFFECT OF GB1 DOMAIN FUSION ON UPREGULATION OF RECOMBINANT PROTEIN EXPRESSION IN PLANT

IONIZABLE CATIONIC LIPID FOR MESSENGER RNA DELIVERY

NUCLEIC ACID VACCINES

INFLUENZA VACCINES

MODIFIED ALPHAVIRUSES WITH HETEROLOGOUS NONSTRUCTURAL PROTEINS

NUCLEIC ACID VACCINES

IMMUNOGENIC COMPOSITIONS AND THEIR USE

NUCLEIC ACID VACCINES

Nucleic acid vaccines

UNIVERSAL VACCINE FOR INFLUENZA VIRUS BASED ON TETRAMERIC M2 PROTEIN INCORPORATED INTO NANODISCS

POLYNUCLEOTIDES AND USES THEREOF

COMPOSITIONS AND METHODS FOR MULTIVALENT SURFACE DISPLAY ON ENVELOPED PARTICLES

ATTENUATION METHOD OF INFLUENZA VIRUS, ATTENUATED INFLUENZA VIRUS STRAIN, AND USE THEREOF

OLIGOMERIZATION PARTICLE FORMATION FUSION PROTEIN WITH IMMUNOGENIC ANTIGEN

RECOMBINANT VIRUS CONTAINING DEGRON, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

Influenza virus hemagglutinin proteins and uses thereof

Glycoengineered Foldon Domains and Related Compositions and Methods

METHOD OF PRODUCING NEGATIVE-STRAND RNA VIRUS VECTOR AND PRODUCED NEGATIVE-STRAND RNA VIRUS VECTOR

SELF-AMPLIFYING MESSENGER RNA

RNA-ONLY DERIVED ORTHOMYXOVIRUSES AND ASSOCIATED VECTORS AND USES THEREOF

CONSTRUCTION AND APPLICATION OF RECOMBINANT H5N8 SUBTYPE AVIAN INFLUENZA VIRUS CARRYING MAPPLE FLUORESCENCE REPORTER GENE

Stabilized influenza hemagglutinin stem region trimers and uses thereof

TEMPERATURE-CONTROLLABLE, SELF-REPLICATING RNA VACCINES FOR VIRAL DISEASES

ANTIBODY-BASED ANTIVIRUS COMPOSITIONS AND METHODS OF USE

RECOMBINANT HVT VECTORS EXPRESSING INFLUENZA HEMAGGLUTININ AND IMMUNOGENIC COMPOSITIONS, AND PRODUCTION AND USES THEREOF

INFLUENZA VIRUS NUCLEIC ACID LIPID PARTICLE VACCINE

MODIFIED CORONAVIRUS STRUCTURAL PROTEIN

INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME

Ferritin Proteins

POLYNUCLEOTIDES CAPABLE OF ENHANCED PROTEIN EXPRESSION AND USES THEREOF

ENGINEERED INFLUENZA VIRUSES EXPRESSING SARS-COV-2 ANTIGENS, VACCINES AND METHODS OF MAKING AND USING THE SAME

LIMITED SELF-REPLICATING MRNA MOLECULAR SYSTEM, PRODUCING METHOD AND USE

Dendritic Cell-Targeting Universal Vaccine for Influenza Infection

IMMUNOGENIC COMPOSITIONS

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME

NOVEL REPLICATION DEFICIENT INFLUENZA A VIRUS INDUCING HIGH LEVELS OF TYPE I INTERFERON

INFLUENZA B VIRUS MUTANTS AND USES THEREFOR

COMPOSITIONS AND METHODS FOR THE GENETIC MANIPULATION OF THE INFLUENZA VIRUS

STABILIZED GROUP 2 INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF

MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY

Fluorocarbon-Linked Peptide Formulation

WW-DOMAIN-ACTIVATED EXTRACELLULAR VESICLES

Destroying Cancer Cells While Maintaining Healthy Cell Integrity

RECOMBINANT HVT AND USES THEREOF

UNIVERSAL MAMMALIAN INFLUENZA VACCINE

Stabilized influenza hemagglutinin stem region trimers and uses thereof

Epitope focusing by variable effective antigen surface concentration

Hemagglutinin Modifications for Improved Influenza Vaccine Production

Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same

RECOMBINANT ARTERIVIRUS REPLICON SYSTEMS AND USES THEREOF

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

Influenza virus replication for vaccine development

STRAIN DIS-DERIVED RECOMBINANT VACCINIA VIRUS HAVING NOVEL INFLUENZA VIRUS-DERIVED HEMAGGLUTININ PROTEIN GENE

INFLUENZA VIRUS SURFACE PROTEIN-DERIVED RECOMBINANT HEMAGGLUTININ PROTEIN FORMING TRIMER, AND USE THEREOF

VIRAL NUCLEIC ACID MOLECULES, AND COMPOSITIONS AND METHODS OF USE THEREOF

Suprastructure Comprising Modified Influenza Hemagglutinin With Reduced Interaction With Sialic Acid

RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF

SARS-COV-2 CHIMERIC VLP VACCINE COMPOSITION, EXPRESSING VECTOR AND USE THEREOF

BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING

Influenza virus vaccines and uses thereof

Influenza virus mutants and uses therefor

RECOMBINANT NEURAMINIDASE AND USES THEREOF

Vaccine compositions having improved stability and immunogenicity

Live Attenuated Universal Influenza Virus Vaccines, Methods and Uses Thereof

Whole avian-origin reverse genetic system and recombinant H5N2 subtype avian influenza virus, vaccine and uses thereof

Whole avian-origin reverse genetic system and its use in producing H7N9 subtype avian influenza vaccine

Methods of optimizing nucleotide sequences encoding engineered influenza proteins

VIRAL MEDIATED GENE DELIVERY FOR TRANSIENT EXPRESSION OF PROTEINS

Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

MODIFIED VIRUS-LIKE PARTICLES OF CMV

INFLUENZA HEMAGGLUTININ PROTEINS AND METHODS OF USE THEREOF

Adenoviral vector system for gene delivery

Targeted RNA cleavage with CRISPR-Cas

PROTEOLYSIS-TARGETING VIRUS, LIVE VACCINE THEREOF, PREPARATION METHOD AND USE THEREOF

Influenza virus hemagglutinin proteins and uses thereof

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

RECOMBINANT NON-STRUCTURAL PROTEIN 1, RECOMBINANT INFLUENZA VIRUS AND IMMUNOLOGICAL COMPOSITION INCLUDING THE SAME, AND METHOD OF TREATING OR PREVENTING DISEASE OR CONDITION CAUSED BY OR ASSOCIATED WITH INFLUENZA VIRUS

NUCLEIC ACID BASED COMBINATION VACCINES

DRUG-RESISTANT INFLUENZA VIRUS STRAINS

H5N6 recombinant influenza virus, a composition for preparing the same, and a vaccine composition containing the same

Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

INFLUENZA VIRUS-LIKE PARTICLE PRODUCTION IN PLANTS

Chimeric molecules and uses thereof

Recombinant influenza viruses and constructs and uses thereof

Immunogen for broad-spectrum influenza vaccine and application thereof

Materials and methods for respiratory disease control in canines

Modification of engineered influenza hemagglutinin polypeptides

VACCINES AND METHODS

Stabilized influenza hemagglutinin stem region trimers and uses thereof

Mutations that confer genetic stability to additional genes in influenza viruses

Immunogenic composition against avian influenza virus H5 subtype

Broadly reactive immunogens of influenza H3 virus, compositions and methods of use thereof

Influenza virus hemagglutinin mutants

INFLUENZA VIRUS HEMAGGLUTINIIN MUTANTS

INFLUENZA ANTIGEN DELIVERY VECTORS AND CONSTRUCTS

Fusion proteins comprising an anti-CD40 antibody and cancer antigens

Recombinant multivalent influenza viruses

Reverse peptide vaccine

MOSAIC INFLUENZA VIRUS HEMAGGLUTININ POLYPEPTIDES AND USES THEREOF

Plant expression enhancer

Recombinant H7N9 subtype avian influenza virus, inactivated marked vaccine and preparation method thereof

NUCLEIC ACID MOLECULES AND DUAL-FUNCTIONAL PEPTIDES HAVING ANTIVIRAL ACTIVITY AND DELIVERY ACTIVITY, COMPOSITIONS AND METHODS THEREOF

METHODS FOR GENERATING PAN-EPITOPIC IMMUNOGENS OF INFLUENZA H3 VIRUS, COMPOSITIONS AND METHODS OF USE THEREOF

Influenza virus hemagglutinin mutants

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

Epitope restriction for antibody selection

Methods of optimizing nucleotide sequences encoding engineered influenza proteins

Vaccines for human papilloma virus and methods for using the same

Ferritin proteins

EHV insertion site UL43

INHIBITION OF INNATE IMMUNE RESPONSE

Epitope focusing by variable effective antigen surface concentration

Cross-immunizing antigen vaccine and method for preparation thereof

Influenza virus replication for vaccine development

A UNIVERSAL VACCINE AGAINST INFLUENZA

Fluorocarbon-linked peptide formulation

Mucosal adjuvants and delivery systems

Influenza peptides and compositions

REPLICATION-LIMITED MUCOSAL IMMUNE VACCINE FOR INFLUENZA VIRUS

Influenza virus vaccines and uses thereof

H9 avian influenza vaccine strain which differentiates infected from vaccinated animals, and preparation method therefor

Influenza B virus mutants and uses therefor

H5 avian influenza vaccine strain which differentiates infected from vaccinated animals, preparation method therefor, and application

Influenza virus-like particle production in plants

Headless hemagglutin influenza vaccine

VACCINES INTELLIGENTLY PRODUCED BY EPITOPE RECOMBINATION (VIPER) FOR INFLUENZA

MOLECULAR GRAFTING OF COMPLEX, BROADLY NEUTRALIZING ANTIBODY EPITOPES

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

Modification of engineered influenza hemagglutinin polypeptides

Influenza virus vaccine and method of making

Oligomeric vaccines from plants by S-Tag-S-protein fusions

Modified virus-like particles of CMV

Marker for detecting highly pathogenic influenza virus and use thereof

Recombinant arterivirus replicon systems and uses thereof

Stabilized viral class I fusion proteins

Transkingdom platform for therapeutic nucleic acid delivery

Vaccine compositions having improved stability and immunogenicity

INFLUENZA VIRUS AND TYPE 1 DIABETES

Influenza virus mutants and uses therefor

Methods and compositions for immunization against virus

Chimeric molecules and uses thereof

Epitope focusing by variable effective antigen surface concentration

Monoclonal antibodies against hemagglutinin of h5-serotype influenza viruses and their uses, hybridomas producing said antibodies, compositions and diagnostic kits

Universal influenza vaccine targeting virus/host recognition

Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

Recombinant virus, composition comprising the same, and uses thereof

Universal mammalian influenza vaccine

Stabilized influenza hemagglutinin stem region trimers and uses thereof

Materials and methods for respiratory disease control in canines

Influenza virus hemagglutinin proteins and uses thereof

Functional influenza virus like particles (VLPs)

Compositions and methods for vaccination against influenza

Immunogenic Influenza Composition

Neutralizing anti-influenza A virus antibodies and uses thereof

Mucosal adjuvants and delivery systems

Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)

Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same

Influenza peptides and compositions

Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

Vaccines for human papilloma virus and methods for using the same

Recombinant influenza virus-like particles (VLPS) produced in transgenic plants

INFLUENZA ANTIGEN DELIVERY VECTORS AND CONSTRUCTS

Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian H5N1 influenza

INFLUENZA VIRUS VACCINES AND USES THEREOF

METHODS FOR IMPROVING THE EFFICACY OF VACCINE ANTIGENS

Antiviral peptide and use therefor

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

Key phosphorylation site of temperature sensitivity of influenza A virus and use thereof

Method for producing RNA molecule compositions

Highly efficient influenza matrix (M1) proteins

Influenza virus mutants and uses therefor

Immunogenic peptide composition and method

Functional influenza virus-like particles (VLPS)

Influenza virus vector for virotherapy

Influenza virus replication for vaccine development

Multimerization of recombinant protein by fusion to a sequence from lamprey

NUCLEIC ACID VACCINES

Influenza virus vaccines and uses thereof

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA

NUCLEIC ACID VACCINES

Compact bypass and decoupling structure for millimeter-wave circuits

Nucleic acid vaccines

Methods and compositions related to increasing the fidelity of influenza A virus for vaccine development

Computationally optimized broadly reactive antigens for H1N1 influenza

Compositions and methods for vaccination against influenza A virus

ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT

Stabilized viral class I fusion proteins

INFLUENZA NUCLEIC ACID MOLECULES AND VACCINES MADE THEREFROM

High titer recombinant influenza viruses with enhanced replication in vero cells

Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

Dps fusion proteins for use in vaccines and diagnostics

Inhibition of innate immune response

ANTIBODIES AGAINST INFLUENZA VIRUS AND METHODS OF USE THEREOF

OPTIMIZED NUCLEIC ACID MOLECULES

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

H3 influenza A virus

Recombinant Influenza Viruses for Vaccines and Gene Therapy

INFLUENZA VIRUS AND TYPE 1 DIABETES

Methods of treating and preventing influenza infections

Mutations that confer genetic stability to additional genes in influenza viruses

Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases

Influenza hemagglutinin proteins and methods of use thereof

Reverse genetics systems

Live recombinant measles-M2 virus—its use in eliciting immunity against influenza viruses

Attenuated influenza vaccines and uses thereof

Epitope focusing by variable effective antigen surface concentration

Peptide sequences and compositions

Antigenically matched influenza vaccines

Materials and methods for respiratory disease control in canines

Methods of optimizing nucleotide sequences encoding engineered influenza proteins

RECOMBINANT VACCINIA VIRUS HAVING HEMAGGLUTININ PROTEIN GENES DERIVED FROM NOVEL INFLUENZA VIRUSES

Modified H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence

Peptide sequences and compositions

Vaccine compositions having improved stability and immunogenicity

Immunization of avians by administration of non-replicating vectored vaccines

Recombinant vectors expressing antigens of avian influenza virus and uses thereof

Functional influenza virus like particles (VLPs)

Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides

Swine influenza vaccine

Multimerization of recombinant protein by fusion to a sequence from lamprey

INFLUENZA A 2009 PANDEMIC H1N1 POLYPEPTIDE FRAGMENTS COMPRISING ENDONUCLEASE ACTIVITY AND THEIR USE

PIV5-based amplifying virus-like particles

NOVEL INFLUENZA VIRUS

INFLUENZA TREATMENT AND/OR CHARACTERIZATION, HUMAN-ADAPTED HA POLYPEPTIDES; VACCINES

RECOMBINANT H7 HEMAGGLUTININ AND USE THEREOF

Recombinant arterivirus replicon systems and uses thereof

Modified virus-like particles of CMV

Compositions and methods for increasing immunogenicity of glycoprotein vaccines

Vaccine antigens that direct immunity to conserved epitopes

Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith

Highly efficient influenza matrix (M1) proteins

Dual purpose universal influenza vaccine confers protective immunity against anthrax

Functional influenza virus-like particles (VLPS)

Functional influenza virus-like particles (VLPs)

Newcastle disease virus vectored avian vaccines

Influenza virus vaccines and uses thereof

Influenza A virus variants

Influenza A virus variants

Vaccine compositions having improved stability and immunogenicity

Computationally optimized broadly reactive antigens for influenza

Stabilized influenza hemagglutinin stem region trimers and uses thereof

Recombinant Influenza Viruses for Vaccines and Gene Therapy

Influenza virus vaccines and uses thereof

Composite antigenic sequences and vaccines

CD40 ligand fusion protein vaccine

Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom

Influenza virus hemagglutinin protein as a vaccine antigen

Particles comprising protamine and RNA in combination with endosome destabilizing agents

Means and methods for breaking noncovalent binding interactions between molecules

Mucosal adjuvants and delivery systems

Computationally optimized broadly reactive antigens for H1N1 influenza

Vaccines for use in the prophylaxis and treatment of influenza virus disease

Computationally optimized broadly reactive antigens for human and avian H5N1 influenza

Influenza virus reassortment